Compugen (NASDAQ: CGEN) reported Q2 EPS of ($0.02), $0.07 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $2.43 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.